Sato Vicki L
- SEC CIK
- 0001197020
In the past year, 8 open-market sale filings worth $1.60M and no purchases.
Current role at each company
- ALLO Allogene Therapeutics, Inc.Directoras of Jun 23, 2026
- VIR Vir Biotechnology, Inc.Directoras of May 4, 2026
- DNLI Denali Therapeutics Inc.Directoras of Jan 3, 2025
- AKUS Akouos, Inc.Directoras of Dec 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.60M
- 8 filings
- Net
- −$1.60M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sato Vicki L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VIR Vir Biotechnology, Inc.
Director34 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Sato Vicki LDirector | SSale | −15.2K | $37.20 | −$564.5K | −0.9%1.63M after | 2 lots |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Sato Vicki LDirector | SSale | −15.2K | $45.05 | −$683.6K | −0.9%1.61M after | 2 lots |
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Sato Vicki LDirector | SSale | −15.2K | $52.48 | −$796.3K | −0.9%1.60M after | 2 lots |
| Oct 20, 2021 (view filing) | Oct 19 | 1 day | Sato Vicki LDirector | SSale | −15.2K | $39.56 | −$600.3K | −1.0%1.58M after | 2 lots |
| Nov 30, 2021 (view filing) | Nov 26 | 4 days | Sato Vicki LDirector | SSale | −15.2K | $36.80 | −$558.4K | −1.0%1.57M after | |
| Dec 21, 2021 (view filing) | Dec 20 | 1 day | Sato Vicki LDirector | SSale | −15.2K | $54.53 | −$827.5K | −1.0%1.55M after | 5 lots |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Sato Vicki LDirector | SSale | −15.2K | $37.39 | −$567.3K | −1.0%1.54M after | |
| May 2, 2022 (view filing) | Apr 28 | 4 days | Sato Vicki LDirector | SSale | −17.9K | $20.90 | −$374.4K | −1.2%1.52M after | 2 lots |
| May 10, 2022 (view filing) | May 9 | 1 day | Sato Vicki LDirector | SSale | −14.5K | $20.62 | −$299.8K | −1.0%1.50M after | |
| May 25, 2022 (view filing) | May 24 | 1 day | Sato Vicki LDirector | SSale | −3.37K | $23.82 | −$80.4K | −0.2%1.51M after |
DNLI Denali Therapeutics Inc.
Director23 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 23, 2021 (view filing) | Jul 21 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $65.13 | −$108.5K | −1.2%132.8K after | 3 lots |
| Aug 20, 2021 (view filing) | Aug 18 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $51.70 | −$86.1K | −1.3%131.2K after | 2 lots |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $53.40 | −$89.0K | −1.3%129.5K after | 4 lots |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $50.05 | −$83.4K | −1.3%127.8K after | |
| Nov 12, 2021 (view filing) | Nov 10 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $52.81 | −$88.0K | −1.3%126.2K after | 2 lots |
| Jun 30, 2023 (view filing) | Jun 28 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $29.84 | −$49.7K | −1.2%134.7K after | 2 lots10b5-1 |
| Jul 19, 2023 (view filing) | Jul 17 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $29.60 | −$49.3K | −1.2%133.0K after | 10b5-1 |
| Aug 17, 2023 (view filing) | Aug 15 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $24.30 | −$40.5K | −1.3%131.4K after | 10b5-1 |
| Sep 19, 2023 (view filing) | Sep 15 | 4 days | Sato Vicki LDirector | SSale | −1.67K | $23.62 | −$39.3K | −1.3%129.7K after | 2 lots10b5-1 |
| Oct 18, 2023 (view filing) | Oct 16 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $20.66 | −$34.4K | −1.3%128.0K after | 10b5-1 |